What Analysts Are Saying About CVS Health Stock
Portfolio Pulse from Benzinga Insights
CVS Health (NYSE:CVS) has been analyzed by 17 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target has decreased by 19.06% to $71.29. Several analysts have lowered their price targets and ratings for CVS Health, reflecting a cautious outlook.
May 30, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
CVS Health has received mixed analyst ratings, with a notable decrease in the average 12-month price target by 19.06% to $71.29. Several analysts have lowered their ratings and price targets, indicating a cautious outlook.
The decrease in the average price target and multiple analysts lowering their ratings and price targets suggest a cautious outlook for CVS Health. This could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100